Thomas G Hullinger
Overview
Explore the profile of Thomas G Hullinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
588
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jaroch D, Liu Y, Kim A, Katz S, Cox B, Hullinger T
J Vasc Interv Radiol
. 2024 Nov;
36(3):499-504.e1.
PMID: 39586533
This study aimed to test the hypothesis that pressure-enabled drug delivery (PEDD) with a pressure-modulating microcatheter device (TriNav; TriSalus Life Sciences, Westminster, Colorado) would increase delivery of microspheres via hepatic...
2.
Jaroch D, Liu Y, Kim A, Katz S, Cox B, Hullinger T
J Vasc Interv Radiol
. 2024 Jul;
35(10):1525-1533.e4.
PMID: 38969336
Purpose: To test the hypothesis that Pressure-Enabled Drug Delivery (PEDD) would improve the delivery of surrogate therapeutic glass microspheres (GMs) via hepatic artery infusion to liver tumors when compared with...
3.
Dickinson B, Semus H, Montgomery R, Stack C, Latimer P, Lewton S, et al.
Eur J Heart Fail
. 2013 Feb;
15(6):650-9.
PMID: 23388090
Aims: Recent studies have shown that microRNAs (miRNAs), besides being potent regulators of gene expression, can additionally serve as circulating biomarkers of disease. The aim of this study is to...
4.
Hullinger T, Montgomery R, Seto A, Dickinson B, Semus H, Lynch J, et al.
Circ Res
. 2011 Nov;
110(1):71-81.
PMID: 22052914
Rationale: Myocardial infarction (MI) is a leading cause of death worldwide. Because endogenous cardiac repair mechanisms are not sufficient for meaningful tissue regeneration, MI results in loss of cardiac tissue...
5.
Montgomery R, Hullinger T, Semus H, Dickinson B, Seto A, Lynch J, et al.
Circulation
. 2011 Sep;
124(14):1537-47.
PMID: 21900086
Background: Diastolic dysfunction in response to hypertrophy is a major clinical syndrome with few therapeutic options. MicroRNAs act as negative regulators of gene expression by inhibiting translation or promoting degradation...